Search for: "In Interest of Ep" Results 621 - 640 of 1,009
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Dec 2022, 4:22 am by Annsley Merelle Ward
As strong authentication is required already for the Sunrise Period the initial timeline seems insufficient in view of the legitimate interests of users who have to find a provider and acquire the required authentication tools. [read post]
2 Feb 2022, 5:58 am by Florian Mueller
An interesting benchmark: OPPO outperformed Daimler against Sharp.Daimler's litigation department managed that litigation a bit like people who order whatever item on the restaurant menu is priciest. [read post]
26 Dec 2013, 7:15 am
According to Mike's Wikipedia entry, he"has an interest in protecting intellectual property rights and is a member of the All-Party Parliamentary Intellectual Property Group. [read post]
16 Jan 2023, 4:30 am by Florian Mueller
OPPO has similarly challenged patents beyond the ones Nokia is asserting.I reported on last year's EP'819 infringement hearing. [read post]
2 Dec 2019, 12:23 am
It is noteworthy that in the pending US proceedings, the US Department of Justice (Antitrust Division) filed on 25 October 2019 a Statement of Interest (available here) on the antitrust aspects of the anti-suit injunction (arguing that the anti-suit injunction sought by Lenovo and Motorola did not have a basis in antitrust law). [read post]
30 Dec 2019, 6:20 am
This would not be in the interest of efficiently conducting patent proceedings. [read post]
29 Jan 2019, 3:11 pm
BackgroundThe patent in issue is EP(UK) 2 269 603 entitled "Treatment of breast tumours with a rapamycin derivative in combination with exemestane". [read post]
4 Aug 2014, 8:40 am
Professor Calvo is the editor of this 368 page issue which includes the very interesting contents listed below.José Calvo GonzálezPresentación, pp. 11-20Jesús Rodríguez-VelascoVoz Muerta. [read post]
23 Mar 2018, 4:26 am
The Dutch EP patent was thus revoked. [read post]
22 May 2014, 8:44 am
That Kat can barely move for the number of interesting cases emerging from the Patents Court at the moment. [read post]
5 Jan 2020, 12:02 pm by Steve Kalar
   Interesting that this civil case settles just as waves of Hondurans are now targeted for small-scale drug scales in the new “Federal Initiative for the Tenderloin. [read post]
9 Jan 2015, 2:11 am
In appeal proceedings for T 557/13 (Infineum), relating to EP0921183 (see the EP register here), the Board of Appeal have recently decided to refer one or more questions to the Enlarged Board of Appeal. [read post]
23 Aug 2019, 4:29 pm by editor@howarddc.com
"  Instead, EPA states that it has decided to provide an opportunity to comment in this instance "because of the potential significant  interest from the public" and to be "completely transparent about these applications. [read post]
27 Jan 2019, 1:53 am
The case concerned the combination product of abacavir and lamivudine for the treatment of HIV, Swiss SPC C00817637/01, based on EP 081 637 B1. [read post]
22 Mar 2020, 5:42 am by Magdaleen Jooste
Here are some interesting IP news from around the globe to keep you entertained. [read post]
2 Feb 2022, 11:07 pm by Florian Mueller
"The following passage on Toyota is...well, interesting:"Toyota aims to sell 10.29 million vehicles across the group in the fiscal year ending March 2022. [read post]
20 Feb 2014, 8:16 am by WIMS
 I've previously described what is at stake in the case here and here and, in the interest of full disclosure, helped author a brief in support of EPA's position. [read post]
1 Sep 2020, 1:00 am by Peter Ling
This would not be the case if the alleged effect depends on subjective interests or preferences of the user. [read post]
1 Mar 2023, 1:00 am by Henry P Yang
It would be interesting to see how the referral questions are phrased by the Court of Appeal and whether the referral is joined with any pending one. [read post]
9 Feb 2017, 1:26 am
  Briggs and Sales LJ qualified this conclusion (obiter) in that the time value of money may need to be taken into consideration in assessing outstanding benefit and the employee's fair share in the event that the real value of money over time had changed (e.g. as a result of inflation or interest rates). [read post]